| 1. |
Matunis MJ，Michael WM，Dreyfuss G.Characterization and primary structure of the poly（C）-binding heterogenous nuclear ribonicleoprotein complex K protein.Mol Cell Biol，1992，12：164-171.
|
| 2. |
Brendel C，Rehbein M，Kreienkamp HJ，et al.Characterization of Staufen 1 ribonucleoprotein complexes.Biochem J，2004，384：239-246.
|
| 3. |
Pino I，Pío R，Toledo G，et al.Altered patterns of expression of members of the heterogeneous nuclear ribonucleoprotein（hnRNP） family in lung cancer.Lung Cancer， 2003，41：131-143.
|
| 4. |
Mandal M，Vadlamudi R，Nguyen D，et al.Growth factors regulate heterogeneous nuclear ribonucleoprotein K expression and function.J Biol Chem，2001，276：9699-9704.
|
| 5. |
Schullery DS，Ostrowski J，Denisenko ON，et al.Regulated interaction of protein kinase Cdelta with the heterogeneous nuclear ribonucleoprotein K protein.J Biol Chem，1999，274：15101-15109.
|
| 6. |
de Hoog CL，Foster LJ，Mann M.RNA and RNA binding proteins participate in early stages of cell spreading through spreading initiation centers.Cell，2004，117：649-662.
|
| 7. |
Hannon GJ.RNA interference.Nature，2002，418：244-251.
|
| 8. |
Rye PD，Stigbrand T.Interfering with cancer：a brief outline of advances in RNA interference in oncology.Tumour Biol，2004，25：329-336.
|
| 9. |
Tan FL，Yin JQ.RNAi，a new therapeutic strategy against viral infection.Cell Res，2004，14：460-466.
|
| 10. |
Pomerantz RJ.RNA interference：a potential novel therapeutic combating HIV-1 in the central nervous system.Arch Immunol Ther Exp（Warsz），2004，52：401-409.
|
| 11. |
Sui G，Soohoo C，Affar el B，et al.A DNA vector-based RNAi technology to suppress gene expression in mammalian cells.Proc Natl Acad Sci U S A，2002，99：5515-5520.
|
